Redefining clinical trials: Adopting AI for speed, volume and diversity
IBM Services
MAY 6, 2024
In this chapter of the IBM series on clinical trial innovation, we spotlight key strategies for boosting recruitment speed, helping to ensure diversity, and harnessing digital advancements. Industry analysts report that dropout rates in phase 3 clinical trials can sometimes reach 20% to 30%.
Let's personalize your content